Johnson & Johnson Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, and Other Innovation Programs

News provided by

Jan 10, 2024, 18:45 ET

DUBLIN, Jan. 10, 2024 /PRNewswire/ -- The "Johnson & Johnson - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com's offering.

Johnson & Johnson (J&J) and its subsidiary companies are engaged in the research & development, production and sale of a variety of human healthcare and wellbeing products.

The company operates through three business segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers a wide range of personal healthcare products such as skin health/beauty products, oral care products, baby care products, over-the-counter medicines, over-the-counter medicines, women's health, and wound care products.

The Pharmaceutical segment develops and sells medicines for treating infectious diseases, immunology disorders, cancer, neurology disorders, cardiovascular and metabolic diseases, and pulmonary hypertension. The Medical Devices segment develops a variety of products for orthopedics, interventional solutions, vision, and surgery. J&J distributes pharmaceutical and medical products through retailers, wholesalers, healthcare professionals and hospitals.

The report provides information and insights into Johnson & Johnson's tech activities, including:

Insights of its digital transformation strategies and innovation programs
Overview of technology initiatives covering partnerships, product launches and acquisitions
Insights on each technology initiative including technology theme, objective, and benefits
Details of estimated ICT budgets and major ICT contracts

Scope

J&J is combining advanced technologies, including artificial intelligence (AI), machine learning (ML), data science, digital health, 3D printing, and real-world evidence (RWD) with large volumes of anonymized patient data to understand disease progression and quickly develop drugs for them.
Johnson & Johnson Medical Devices Companies (JJDMC), a subsidiary of J&J, is developing a platform on Microsoft Azure that will enable the company to connect and manage several Internet of Things (IoT)-enabled medical devices, process data from hospital and data records, and track its digital surgery ecosystem from one dashboard.
J&J teamed up with TCS for their digital transformation journey to build a technology stack, improve customer experience, and explore new business opportunities. By leveraging TCS' IoT expertise, the company developed open-source IoT platforms to drive innovation and agility in product development and supply chain processes.
J&J has made significant investments in data science, establishing a Data Science Council consisting of members from different departments. The council's objective is to leverage data for informed decision-making and continuously develop innovative drugs and surgical solutions.

Reasons to Buy

Gain insights into Johnson & Johnson's tech operations.
Gain insights into its tech strategies and innovation initiatives.
Gain insights into its technology themes under focus.
Gain insights into various product launches, partnerships and acquisition strategies.

Key Topics Covered:

Overview
Digital Transformation Strategy
Accelerators, Incubators, and Other Innovation Programs
Technology Focus
Technology Initiatives
Venture Arm: Johnson Johnson Innovation JJDC, Inc
Investment
Acquisitions
Partnership, Investment & Acquisition Network Map
ICT Budget and Contracts
Key Executives
Contact the Publisher

A selection of companies mentioned in this report includes

Apple
artera
microsoft
verb surgical
medcrypt
iktos
SciBase Holding
Zebra Medical
Koa Health

For more information about this company profile visit https://www.researchandmarkets.com/r/qpz11k

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo - https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets